X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
heart failure (151) 151
cardiac & cardiovascular systems (136) 136
humans (130) 130
female (97) 97
male (93) 93
aged (86) 86
mortality (81) 81
middle aged (75) 75
heart failure - drug therapy (53) 53
abridged index medicus (46) 46
heart failure - physiopathology (46) 46
risk factors (44) 44
cardiac and cardiovascular systems (38) 38
kardiologi (38) 38
prognosis (38) 38
heart failure - mortality (37) 37
treatment outcome (35) 35
outcomes (32) 32
hospitalization (31) 31
risk (31) 31
enalapril (29) 29
aged, 80 and over (28) 28
cardiovascular (28) 28
care and treatment (27) 27
survival (27) 27
morbidity (24) 24
adult (23) 23
diabetes (23) 23
hospitalization - statistics & numerical data (23) 23
patient outcomes (23) 23
tetrazoles - therapeutic use (23) 23
analysis (22) 22
heart diseases (22) 22
peripheral vascular disease (22) 22
heart failure - epidemiology (21) 21
clinical medicine (20) 20
epidemiology (20) 20
heart failure - complications (20) 20
klinisk medicin (20) 20
stroke volume - physiology (20) 20
cardiovascular system & cardiology (19) 19
clinical trials (19) 19
diabetes mellitus (19) 19
medicine, general & internal (19) 19
stroke volume (19) 19
trial (18) 18
cardiac patients (17) 17
ejection fraction (17) 17
heart failure - diagnosis (17) 17
prospective studies (17) 17
association (16) 16
cardiovascular diseases (16) 16
comorbidity (16) 16
death (16) 16
double-blind method (16) 16
management (16) 16
cardiovascular disease (15) 15
internal medicine (15) 15
neprilysin (15) 15
prevalence (15) 15
risk assessment (15) 15
survival rate - trends (15) 15
time factors (15) 15
age (14) 14
drug therapy (14) 14
follow-up studies (14) 14
incidence (14) 14
kaplan-meier estimate (14) 14
retrospective studies (14) 14
angiotensin receptor antagonists - therapeutic use (13) 13
patients (13) 13
research (13) 13
aminobutyrates - therapeutic use (12) 12
angiotensin-converting enzyme inhibitors - therapeutic use (12) 12
candesartan (12) 12
cardiology (12) 12
disease (12) 12
dysfunction (12) 12
heart failure - therapy (12) 12
heart-failure (12) 12
irbesartan (12) 12
neprilysin inhibition (12) 12
risk-factors (12) 12
scotland - epidemiology (12) 12
stroke (12) 12
therapy (12) 12
angiotensin ii type 1 receptor blockers - therapeutic use (11) 11
cardiomyopathy (11) 11
heart (11) 11
impact (11) 11
preserved ejection fraction (11) 11
randomized controlled trials as topic (11) 11
adrenergic beta-antagonists - therapeutic use (10) 10
angiotensin (10) 10
atrial fibrillation (10) 10
converting-enzyme inhibitors (10) 10
coronary artery disease (10) 10
diagnosis (10) 10
health aspects (10) 10
inhibition (10) 10
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 1533-4406, 2017, Volume 377, Issue 1, pp. 41 - 51
Journal Article
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2019, Volume 381, Issue 21, pp. 1995 - 2008
In this randomized, placebo-controlled trial, investigators evaluated the effects of the sodium–glucose cotransporter 2 inhibitor dapagliflozin in patients... 
NEPRILYSIN INHIBITION | OUTCOMES | COTRANSPORTER 2 INHIBITORS | MECHANISM | EMPAGLIFLOZIN | MEDICINE, GENERAL & INTERNAL | CARDIOVASCULAR OUTCOMES | Glycated Hemoglobin A - analysis | Humans | Middle Aged | Ventricular Dysfunction, Left - complications | Male | Benzhydryl Compounds - adverse effects | Cardiovascular Diseases - mortality | Female | Glucosides - therapeutic use | Drug Therapy, Combination | Benzhydryl Compounds - therapeutic use | Diabetes Mellitus, Type 2 - complications | Glucosides - adverse effects | Heart Failure - complications | Sodium-Glucose Transporter 2 Inhibitors - therapeutic use | Sodium-Glucose Transporter 2 Inhibitors - adverse effects | Kaplan-Meier Estimate | Stroke Volume - drug effects | Combined Modality Therapy | Hospitalization | Heart Failure - drug therapy | Cardiovascular Agents - therapeutic use | Diabetes Mellitus, Type 2 - blood | Ventricular Dysfunction, Left - drug therapy | Aged | Diabetes Mellitus, Type 2 - drug therapy | Type 2 diabetes | Measurement | Heart failure | Dapagliflozin | Patient outcomes | Physiological aspects | Cardiac output | Drug therapy | Testing | Intravenous administration | Renal function | Clinical trials | Hypoglycemia | Evidence-based medicine | Clinical outcomes | Sodium | Hemoglobin | Patient safety | Diabetes | Diabetes mellitus (non-insulin dependent) | Heart diseases | Drug dosages | Ejection fraction | Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 2015, Volume 66, Issue 19, pp. 2059 - 2071
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2019, Volume 381, Issue 17, pp. 1609 - 1620
Journal Article
Heart, ISSN 1355-6037, 11/2018, Volume 104, Issue 22, pp. 1812 - 1813
Journal Article
Journal Article
Heart, ISSN 1355-6037, 02/2019, Volume 105, Issue 4, pp. 337 - 345
Journal Article